Skip to content

13F-HR filed by Healthcare Value Capital, LLC

Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-13, with 10 holding rows worth $25,727,000.

Accession
0000919574-19-001087
Filed
2019-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 10 entries on the cover page, a total value of $25,727,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $25,727,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TYME TECHNOLOGIES INC COM90238J103Stock2,175,000$8,023,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM450,000$3,879,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR100,000$3,821,000thousands by filing date
PROSHARES TR ULTSH NASD BIOT74347B789CEF150,000$3,449,000thousands by filing date
ALLERGAN PLCG0177J108SHS20,000$2,673,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW1,800,000$1,548,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM100,000$765,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM100,000$765,000thousands by filing datecall
ANTARES PHARMA INC036642106COM250,000$680,000thousands by filing date
LANNETT COMPANY INCORPORATED516012101COM25,000$124,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-19-001087this filing2019-02-13acceptance time not in the bulk data set